Organoprotective effects of glucagon-like peptide-1 receptor agonists with regard to findings of evidencebased cardiovascular safety studies

The article discusses the potential opportunities for impact of antidiabetic drugs from the group of glucagon-like peptide-1 (GLP- 1) receptor agonists on the risks of development and progression of cardiovascular complications in patients with type 2 diabetes mellitus (T2DM) and their possible role...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yu. Sh. Khalimov, V. G. Kuzmich
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Remedium Group LLC 2020-01-01
Serie:	Медицинский совет
Soggetti:	diabetes mellitus incretins glucagon-like peptide-1 receptor agonists obesity cardiovascular risk cardiovascular complications renal complications
Accesso online:	https://www.med-sovet.pro/jour/article/view/5493
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!